NexGenix Pharmaceuticals Revenue

Pharmaceutical Manufacturing • United States • 1-10 Employees

NexGenix Pharmaceuticals revenue & valuation

Annual revenue	$4,420,000
Revenue per employee	$884,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$14,200,000
Total funding	$3,900,000

Key Contact at NexGenix Pharmaceuticals

Ruihong Chen

Director

Company overview

Headquarters	United States
Phone number	+19172103377
Website	nexgenixpharm.com
NAICS	3254
Employees	1-10
Socials

NexGenix Pharmaceuticals Email Formats

NexGenix Pharmaceuticals uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@nexgenixpharm.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@nexgenixpharm.com	100%

About NexGenix Pharmaceuticals

NexGenix is a privately-held drug discovery and development company focused on the "next generation" of targeted therapies for cancer and diseases of the nervous system such as glioblastoma, neurodegenerative diseases, neurofibromatosis, and autism-spectrum disorders. The Company has acquired, through in-licensing and research collaboration, a robust structural chemistry platform in resorcylic macrolides, highly potent inhibitors of the chaperone, heat shock protein 90 (Hsp90). The concept that numerous diseases, including cancer, neurofibromatosis, amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) and Parkinson's disease involve misregulation of protein homeostasis presents a unique opportunity for drug development for these varied disorders. NexGenix's novel Hsp90 inhibitors, based on the highly potent compound radicicol, exhibit the potential to be best in class drugs. NexGenix has world-class scientific advisors and collaborators in the areas of protein folding, kinase signaling and oncogenesis, and neurodegenerative diseases. The company additionally has a growing portfolio of intellectual property covering its key efforts.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Funding Data

Explore NexGenix Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2007-08-16	5	$3,900,000

Funding Insights

$3,900,000

Total funding amount

$3,900,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

NexGenix Pharmaceuticals is located in US.

You can reach NexGenix Pharmaceuticals at +19172103377.

NexGenix Pharmaceuticals generates an estimated annual revenue of $4,420,000. This revenue figure reflects the company's market position and business performance in its industry.

NexGenix Pharmaceuticals has an estimated valuation of $14,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

NexGenix Pharmaceuticals has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

NexGenix Pharmaceuticals has raised a total of $3,900,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at NexGenix Pharmaceuticals

Ruihong Chen

Director

4.8

40,000 users